Explain this page
Arphra AIPlain-English read on Mycotopia Therapies, Inc.’s valuationBusiness description
· company · SEC profileMycotopia Therapies, Inc.
Mycotopia Therapies, Inc. specializes in the application of psychedelic compounds to address a range of mental health conditions. The company offers therapeutic interventions for ailments such as post-traumatic stress disorder (PTSD), severe anxiety, depression, and serotonin syndrome, in addition to providing support for palliative care. Headquartered in Aventura, Florida, Mycotopia Therapies, Inc. operates as a subsidiary of EHAVE, Inc.
Founded
—
IPO
Mar 31, 2006
Employees
1
HQ
Aventura, FL
CEO
Benjamin Kaplan
CFO
—
Exchange
OTC
Fiscal year
—
Identifiers
· company_identifiersCIK0001763329
CUSIP62846W107
ISINUS62846W1071
FIGI—
LEI—